LAZCLUZE
Active Ingredient: LAZERTINIB (LAZERTINIB MESYLATE)
Product Overview
About LAZCLUZE
LAZCLUZE is a prescription medication containing the active ingredient Lazertinib (Lazertinib Mesylate), a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It is used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations
- Targeted therapy to inhibit EGFR tyrosine kinase activity
- Oral administration for convenient dosing
Active Ingredient & Action
Lazertinib (Lazertinib Mesylate) works by selectively binding to the EGFR tyrosine kinase domain, thereby inhibiting the phosphorylation of downstream signaling proteins. This leads to a decrease in tumor cell proliferation and an increase in apoptosis, ultimately resulting in tumor growth inhibition.
Important Notes
LAZCLUZE is available only by prescription. It is essential to follow the recommended dosage and administration instructions provided by your healthcare provider. Regular monitoring of liver function and other potential side effects is recommended. Inform your doctor about any medical history, allergies, or current medications before starting treatment with LAZCLUZE.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
Similar Products & Analogs
No analogs found for the selected country.
Show all countries